PET Tau - Neurodegenerative Disease Imaging

Recruiting now · Phase 2/Phase 3

Conditions studied: Neurodegenerative Disease

In brief

The purpose of this study is to measure the amount of a protein in the brain known as tau using an imaging procedure called Positron Emission Tomography (PET/CT). Tau has been shown to build up in the brains of patients with injury to brain cells. This study looks at neurodegenerative diseases such as frontotemporal degeneration (FTD).

Key facts

Study ID

NCT03143374

Run by

University of Pennsylvania

People needed

300

Starts

2016-08-23

Expected to finish

2030-09-01

Last updated by the study team

2025-10-15

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.

Where it is running

• University of Pennsylvania — Philadelphia, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.